ANDREW BISHOP: Open Payments
NPI 1881702710 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 43 payments from 7 companies in 2025. Trend: 2023 $1,239 · 2024 $797 · 2025 $854
Food & beverage: $742Education: $111
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 13 | $227 |
| Teva Pharmaceuticals USA, Inc. | 8 | $215 |
| Neurocrine BioSciences, Inc. | 13 | $198 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $146 |
| Kerecis Limited | 1 | $34 |
| Novo Nordisk Inc | 1 | $20 |
| ABBVIE INC. | 1 | $14 |
Products named: INGREZZA, Sunosi, CAPLYTA, AUSTEDO XR, Auvelity, Kerecis SurgiClose, Rybelsus, VRAYLAR.
Industry payments across MS — which companies pay providers there.
